Epilepsy and sudden death: Personal reflections and call for global action

Epilepsy and Behavior

Volumn 15, Issue 3, 2009, Pages 269-277

  Lathers, Claire M ^a  

^a NONE   (United States)

Author keywords

Beta blockers; Clinical pharmacology; Epilepsy; Global focus to prevent SUDEP; Grants; Leadership; Lessons learned; Selective serotonin reuptake inhibitors; Sudden unexpected death in epilepsy; Train students

Indexed keywords

ANTICONVULSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIAZEPAM; LORAZEPAM; PROPRANOLOL;

ARTICLE; ASYSTOLE; AUTOPSY; BLOOD OXYGEN TENSION; BRADYCARDIA; CAUSE OF DEATH; DISEASE COURSE; DRUG RESEARCH; EDUCATION PROGRAM; ELECTROCARDIOGRAPHY; ELECTROENCEPHALOGRAPHY; EPILEPSY; EPILEPTOGENESIS; HEART ARRHYTHMIA; HEART INFARCTION; HEART INNERVATION; HEART VENTRICLE FIBRILLATION; HUMAN; HYPOXIA; INCIDENCE; MEDICAL CARE; MEDICAL EDUCATION; MEDICAL STUDENT; MORTALITY; NONHUMAN; PARASYMPATHETIC INNERVATION; PARASYMPATHETIC NERVE; PATHOPHYSIOLOGY; PATIENT MONITORING; RESUSCITATION; RISK ASSESSMENT; SUDDEN DEATH; SYMPATHETIC INNERVATION; SYMPATHETIC NERVE;

CAUSE OF DEATH; CONSUMER ADVOCACY; DEATH, SUDDEN; EPILEPSY; HEALTH EDUCATION; HISTORY, 18TH CENTURY; HUMANS;

EID: 67650489214     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2009.04.023     Document Type: Article

References (142)

1. DeToledo J.C., DeToledo M.B., and Lowe M.R. Epilepsy and sudden death: notes from George Washington's diaries on the illness and death of Martha Parke-Custis (1756-1773). Epilepsia 40 (1999) 1835-1836
2. Doherty M.J. The sudden death of Patsy Custis, or George Washington on sudden unexplained death in epilepsy. Epilepsy Behav 5 (2004) 598-600
3. Lathers C.M., Schraeder P.L., and Bungo M. Mystery of sudden death: mechanisms for risks. Epilepsy Behav 12 (2008) 3-24
4. Lathers C.M., Schraeder P.L., and Bungo M.W. Sudden death: neurocardiologic mystery. In: Sher L. (Ed). Psychological factors and cardiovascular disorders (2009), Nova Science Publishers, Inc., New York 263-311 [chapter 13]
5. Lathers C.M., Schraeder P.L., and Bungo M.W. Reply. Epilepsy Behav 13 (2008) 265-269
6. Lathers C.M., Schraeder P.L., and Bungo M.W. Unanswered questions: SUDEP clinical studies needed. In: Lathers C.M., Schraeder P.L., Bungo M.W., and Leestma J.E. (Eds). Sudden death in epilepsy: forensic and clinical issues (2010), CRC Press, Boca Raton, FL
7. Bacon G.M. On the modes of death in epilepsy. Lancet 1 (1868) 555-556
8. Geysen H. De La Mort Inopinee Ou Rapide Chex Les Epileptiques. Thesis, 1895.
9. Spratling W.P. The causes and manner of death in epilepsy. Med News 80 (1902) 1225-1227
10. Terrance C.F. Unexpected, unexplained death of epileptic persons: clinical correlation including pulmonary changes. In: Lathers C.M., and Schraeder P.L. (Eds). Epilepsy and sudden death (1990), Marcel Dekker, New York 89-100
11. Lathers CM. Arrhythmias, seizures, and sudden death: clinical rounds. Rockville, MD: Food and Drug Administration, Center for Drug Evaluation and Research, Cardio-Renal Division; 11 November 1989.
12. Leestma J.E., Annegers J.F., Brodie M.J., et al. Sudden unexplained death in epilepsy: observations from a large clinical trial. Epilepsia 38 (1997) 47-55
13. Lathers CM. Autonomic cardiac neural dysfunction, arrhythmias, and epileptogenic activity. Symposium on Sudden Unexplained Death in Epileptics. Presented at the 15th Epilepsy International Meeting, Hilton Hotel, Washington, DC; 26 September 1983.
14. Lathers C.M., and Roberts J. Are the sympathetic neural effects of digoxin and quinidine involved in their action on cardiac rhythm?. J Cardiovasc Pharmacol 7 (1985) 350-360
15. Lathers C.M., Lipka L.J., and Klions H.A. Controversies and differences in the actions of digitalis glycosides: are all derivatives alike?. J Clin Pharmacol 25 (1985) 501-506
16. Lathers C.M., Lipka L.J., and Klions H.A. Digitalis glycosides: a discussion of the similarities and differences in actions and existing controversies. Rev Clin Basic Pharmacol 7 (1988) 1-108
17. Lathers C.M., Kelliher G.J., Roberts J., and Beasley A.B. Role of the adrenergic nervous system in arrhythmia produced by acute coronary artery occlusion. In: Leffer A.M., Kelliher G.J., and Rovetto M.J. (Eds). Pathophysiology and therapeutics of myocardial ischemia (1977), Book Division of Spectrum Publications, New York 123-147
18. Lathers C.M., Roberts J., and Kelliher G.J. Correlation of ouabain-induced arrhythmia and nonuniformity in the histamine-evoked discharge of cardiac sympathetic nerves. J Pharmacol Exp Ther 203 (1977) 467-479
19. Lathers C.M., Kelliher G.J., Roberts J., and Beasley A.B. Nonuniform cardiac sympathetic nerve discharge: mechanism for coronary occlusion and digitalis-induced arrhythmia. Circulation 57 (1978) 1058-1065
20. Han J., and Moe G.K. Nonuniform recovery of excitability in ventricular muscle. Circ Res 14 (1964) 44-60
21. In: Randall W.C. (Ed). Neural regulation of the heart (1977), Oxford Univ. Press, New York 1-440
22. Randall W.C., Thomas J.X., Euler D.E., and Rozanski G.J. Cardiac dysrhythmias associated with autonomic nervous system imbalance in the conscious dog. In: Schwartz P.J., Brown A.M., Malliani A., and Zanchetti A. (Eds). Perspectives in cardiovascular research: vol. 2. Neural mechanisms in cardiac arrhythmias (1978), Raven Press, New York 123-138
23. In: Randall W.C. (Ed). Nervous control of cardiovascular function (1984), Oxford Univ. Press, New York 1-476
24. Lathers C.M. Effect of timolol on autonomic neural discharge associated with ouabain-induced arrhythmia. Eur J Pharmacol 64 (1980) 95-106
25. Lathers C.M. Induced disease: myocardial infarction in dogs and cats. Mammalian models for research on aging (1981), National Academy Press, Washington, DC 224-228
26. Lathers C.M. Lack of effect of methylprednisolone on cardiac neural discharge associated with coronary occlusion-induced arrhythmia and death. Eur J Pharmacol 85 (1982) 233-238
27. Lathers C.M., and Schraeder P.L. Autonomic dysfunction in epilepsy: characterization of autonomic cardiac neural discharge associated with pentylenetetrazol-induced epileptogenic activity. Epilepsia 23 (1982) 633-647
28. Schraeder P.L., and Lathers C.M. Cardiac neural discharge and epileptogenic activity in the cat: an animal model for unexplained death. Life Sci 32 (1983) 1371-1382
29. Lathers C.M., and Schraeder P.L. Review of autonomic dysfunction, cardiac arrhythmias, and epileptogenic activity. J Clin Pharmacol 27 (1987) 346-356
30. Schraeder P.L., and Lathers C.M. Paroxysmal cardiovascular dysfunction and epileptogenic activity. Epilepsy Res 3 (1989) 55-62
31. Lathers C.M., Gerard-Ciminera J.L., Baskin S.I., Krusz J.C., Kelliher G.J., and Roberts J. The action of reserpine, 6-hydroxydopamine, and bretylium on digitalis-induced cardiotoxicity. Eur J Pharmacol 76 (1981) 371-379
32. Lathers C.M., Gerard-Ciminera J.L., Baskin S.I., et al. Role of the adrenergic nerve terminal in digitalis-induced cardiac toxicity: a study of the effects of pharmacological and surgical denervation. J Cardiovasc Pharmacol 4 (1982) 91-98
33. Pickworth W.B., Gerard-Ciminera J., and Lathers C.M. Stress, arrhythmias, and seizures. In: Lathers C.M., and Schraeder P.L. (Eds). Epilepsy and sudden death (1990), Marcel Dekker, New York 417-447
34. Lathers C.M., Schraeder P.L., and Carnel S.B. Neural mechanisms in cardiac arrhythmias associated with epileptogenic activity: the effect of phenobarbital. Life Sci 34 (1984) 1919-1936
35. Carnel S.B., Schraeder P.L., and Lathers C.M. The effect of phenobarbital pretreatment on cardiac neural discharge and pentylenetetrazol-induced epileptogenic activity. Pharmacology 20 (1985) 225-240
36. Suter L., and Lathers C.M. Modulation of presynaptic gamma aminobutyric acid release by prostaglandin E2: explanation for epileptogenic activity and dysfunction in autonomic cardiac neural discharge leading to arrhythmias. Med Hypotheses 15 (1984) 15-30
37. Lathers C.M., Spivey W.H., Suter L.E., Lerner J.P., Tumer N., and Levin R.M. The effect of acute and chronic administration of timolol on cardiac sympathetic neural discharge, arrhythmia, and beta adrenergic receptor density associated with coronary occlusion in the cat. Life Sci 39 (1986) 2121-2141
38. Lathers C.M., and Lipka L.J. Chlorpromazine: cardiac arrhythmogenicity in the cat. Life Sci 38 (1986) 521-538
39. Lathers C.M., Flax R.F., and Lipka J. The effect of C1 spinal cord transection or bilateral adrenal vein ligation on thioridazine-induced arrhythmia and death in the cat. J Clin Pharmacol 26 (1986) 515-523
40. Lipka L.J., and Lathers C.M. Psychoactive agents, seizure production, and sudden death in epilepsy. J Clin Pharmacol 27 (1987) 169-183
41. Lathers C.M., and Lipka L.J. Cardiac arrhythmia, sudden death, and psychoactive agents. J Clin Pharmacol 27 (1987) 1-14
42. Lipka L.J., Lathers C.M., and Roberts J. Does chlorpromazine produce cardiac arrhythmia via the central nervous system?. J Clin Pharmacol 28 (1988) 968-983
43. Kraras C.M., Tumer N., and Lathers C.M. The role of neuropeptides in the production of epileptogenic activity and autonomic dysfunction: origin of arrhythmia and sudden death in the epileptic patient?. Med Hypotheses 23 (1987) 19-31
44. Lathers C.M., Tumer N., and Kraras C.M. The effect of intracerebroventricular D-Ala2-methionine enkephalinamide and naloxone on cardiovascular parameters in the cat. Life Sci 43 (1988) 2287-2298
45. Lathers C.M., Stauffer A., Tumer N., Kraras C.M., and Goldman B.D. Effect of timolol on the electrocorticogram and cardiovascular parameters associated with pentylenetetrazol induced epileptogenic activity in the cat. Epilepsy Res 4 (1989) 42-54
46. Lathers C.M., Tyau L., Spino M., and Agarwal I. Cocaine-induced seizures, arrhythmias, and sudden death. J Clin Pharmacol 28 (1988) 584-593
47. Lathers C.M., Pickworth W.B., Tyau L.S.Y., Spino M.M., and Agarwal I. Cocaine-induced arrhythmias and sudden death. In: Lathers C.M., and Schraeder P.L. (Eds). Epilepsy and sudden death (1990), Marcel Dekker, New York 393-416
48. Lathers C.M., Tumer N., Frame V.B., and Roberts J. Protection of CGS 10078B against ouabain-induced arrhythmia in the cat. Pharmacology 35 (1987) 35-46
49. Lathers C.M., Spivey W.H., and Tumer N. The effect of timolol given five minutes post coronary occlusion on plasma catecholamines. J Clin Pharmacol 28 (1988) 289-299
50. Spivey W.H., Lathers C.M., Malone D.R., et al. A comparison of intraosseous, central and peripheral routes of sodium bicarbonate administration during CPR in pigs. Ann Emerg Med 14 (1985) 1135-1139
51. Lathers C.M., Tumer N., and Schoffstall J.M. The effect of different routes of sodium bicarbonate administration on plasma catecholamines, pH, and blood pressure during cardiac arrest in pigs. Resuscitation 18 (1989) 59-74
52. Lathers C.M., Spivey W.H., Levin R.M., and Tumer N. The effect of dilevalol on cardiac autonomic neural discharge, plasma catecholamines, and myocardial beta receptor density associated with coronary occlusion. J Clin Pharmacol 30 (1990) 241-253
53. Lathers C.M., Schraeder P.L., and Tumer N. The effect of phenobarbital upon autonomic function and epileptogenic activity induced by the hippocampal injection of penicillin in cats. J Clin Pharmacol 33 (1993) 837-844
54. Jim K.F., Lathers C.M., Spivey W.H., Matthews W.D., Kahn C., and Dolce K. Suppression of pentylenetetrazol-elicited seizure activity by intraosseous propranolol in pigs. J Clin Pharmacol 28 (1988) 1106-1111
55. Lathers C.M., Jim K.F., High W., Spivey W.H., Matthews W.D., and Ho T. An investigation of the pathological and physiological effects of intraosseous sodium bicarbonate in pigs. J Clin Pharmacol 29 (1989) 354-359
56. Lathers C.M., Jim K.F., and Spivey W.H. A comparison of intraosseous and intravenous routes of administration for antiseizure agents. Epilepsia 30 (1989) 472-479
57. Jim K.F., Lathers C.M., Farris V.L., Pratt L.F., and Spivey W.H. Suppression of pentylenetetrazol elicited seizure activity by intraosseous lorazepam in pigs. Epilepsia 30 (1989) 480-486
58. Lathers C.M., Jim K.F., Spivey W.H., Kahn C., Dolce K., and Matthews W.D. Antiepileptic activity of beta-blocking agents. In: Lathers C.M., and Schraeder P.L. (Eds). Epilepsy and sudden death (1990), Marcel Dekker, New York 485-505
59. Spivey W.H., and Lathers C.M. Effect of timolol on the sympathetic nervous system in coronary occlusion in cats. Ann Emerg Med 34 (1985) 939-944
60. Lathers C.M., Levin R.M., and Spivey W.H. Regional distribution of myocardial receptors. Eur J Pharmacol 130 (1986) 111-117
61. Spivey W.H., Unger H.D., Lathers C.M., and McNamara R.M. Comparison of the intraosseous and intravenous routes of diazepam for pentylenetetrazol-induced seizures. Ann Emerg Med 16 (1987) 156-159
62. Spivey W.H., Unger H.D., Lathers C.M., and McNamara R.M. Intraosseous diazepam suppression of pentylentetetrazol-induced epileptogenic activity in pigs. Ann Emerg Med 16 (1987) 56-59
63. Rusli M., Spivey W.H., Bonner H., McNamara R.M., Aaron C.K., and Lathers C.M. Pathological effects of endotracheal diazepam in cats. Ann Emerg Med 16 (1987) 314-318
64. Spivey W.H., Unger H.D., McNamara R.M., LaManna M.M., Ho T., and Lathers C.M. The effect of intraosseous sodium bicarbonate on bone in swine. Ann Emerg Med 16 (1987) 773-776
65. Lathers C.M., and Spivey W.H. The effect of timolol, metoprolol, and practolol on postganglionic cardiac neural discharge associated with acute coronary occlusion-induced arrhythmia. J Clin Pharmacol 27 (1987) 582-592
66. Lathers C.M., Spivey W.H., and Levin R.M. The effect of chronic timolol in an animal model for myocardial infarction. J Clin Pharmacol 28 (1988) 736-745
67. Schoffstall J., Spivey W.H., Davidheiser S., and Lathers C.M. Intraosseous crystalloid and blood infusion in a swine model. J Trauma 27 (1989) 384-387
68. Lathers C.M., Schraeder P.L., and Weiner F.L. Synchronization of cardiac autonomic neural discharge with epileptogenic activity: the lock step phenomenon. Electroencephalogr Clin Neurophysiol 67 (1987) 247-259
69. Stauffer A.Z., Dodd-o J.M., and Lathers C.M. The relationship of the lockstep phenomenon and precipitous changes in mean arterial blood pressure. Electroencephalogr Clin Neurophysiol 72 (1989) 340-345
70. Stauffer A.Z., Dodd-o J.M., and Lathers C.M. Relationship of the lockstep phenomenon and precipitous changes in blood pressure. In: Lathers C.M., and Schraeder P.L. (Eds). Epilepsy and sudden death (1990), Marcel Dekker, New York 221-238
71. Dodd-o J.M., and Lathers C.M. A characterization of the lockstep phenomenon in phenobarbital-pretreated cats. In: Lathers C.M., and Schraeder P.L. (Eds). Epilepsy and sudden death (1990), Marcel Dekker, New York 199-220
72. O'Rourke D.K., and Lathers C.M. Interspike interval histogram characterization of synchronized cardiac sympathetic neural discharge and epileptogenic activity in the electrocorticogram of the cat. In: Lathers C.M., and Schraeder P.L. (Eds). Epilepsy and sudden death (1990), Marcel Dekker, New York 239-259
73. In: Lathers C.M., and Schraeder P.L. (Eds). Epilepsy and sudden death (1990), Marcel Dekker, New York
74. In: Lathers C.M., Schraeder P.L., Bungo M.W., and Leestma J.E. (Eds). Sudden death in epilepsy: forensic and clinical issues (2010), Taylor & Francis, New York
75. Wang J., Chen Y., Li K., and Hou L. Blockade of inhibitory neurotransmission evoked seizure-like firing of cardiac parasympathetic neurons in brainstem slices of newborn rats: implications for sudden deaths in patients with epilepsy. Epilepsy Res 70 (2006) 172-183
76. Carnel SB. M.S./M.D. student candidate selected to compete in the Eastern Student Research Forum. Univ. of Miami School of Medicine, Miami, FL; 8-10 February 1982.
77. Munson J.F. Death in epilepsy. Med Rec 77 (1910) 58-62
78. Steinseik H.D. Uber todesursachen und lebensdauer bei genuiner epilepsie. Arch Psych Z Neurol 183 (1950) 469-480
79. Krohn W. Causes of death among epileptics. Epilepsia 4 (1963) 315-321
80. Freytag E., and Lindenberg R. 294 medicolegal autopsies on epileptics. Arch Pathol 78 (1964) 274-286
81. Ziegler H.T., and Kamecke A. Uber unerwarteten tod von epileptikern. Nervenarzt 38 (1967) 343-348
82. Terrance C.F., Wisotzkey H.M., and Perper J.A. Unexpected, unexplained death in epileptic patients. Neurology 25 (1975) 594-598
83. Iivanainen M., and Lehtinen J. Causes of death in institutionalized epileptics. Epilepsia 20 (1979) 485-492
84. Jay G.W., and Leestma J.E. Sudden death in epilepsy. CTA Neurol Scand 63 Suppl. 82 (1981) 1-66
85. Tomson T., Walczak T., Sillanpää M., and Sander J. Sudden unexpected death in epilepsy: a review of incidence and risk factors. Epilepsia 46 Suppl. 11 (2005) 54-61
86. Schraeder P.L., Delin Kristen, McClelland R.L., and So E.L. Coroner and medical examiner documentation of sudden unexplained deaths in epilepsy. Epilepsy Res 68 (2006) 137-143
87. Schraeder PL, Delin K, McClelland RL, So, EL. A nationwide survey of the extent of autopsy examinations in sudden unexplained death in epilepsy. J Forens Med Pathol 2009, in press.
88. Lathers C.M., and Schraeder P.L. Verbal autopsies. Epilepsy Behav 14 (2009) 573-576
89. Chadwick D., Jenner P., and Reynolds E.H. Amines, anticonvulsants, and epilepsy. Lancet 1 (1975) 473-476
90. Oishi R., Suenaga N., and Fukada T. Possible involvement of brain stem norephinephrine in pentylenetetrazol convulsions in rats. Pharmacol Biochem Behav 10 (1979) 57-61
91. Mason S.T., and Corcoran M.E. Catecholamines and convulsions. Brain Res 170 (1979) 479-507
92. Ceremuzynski L., Staszewska-Barczak J., and Herbaczynska-Cedro K. Cardiac rhythm disturbances and the release of catecholamines after acute coronary occlusion in dogs. Cardiovasc Res 3 (1969) 190-197
93. Proakis A.G., Borowitz J.L., McDougal M.R., and Spratto G.R. Interaction between acetylcholine and sotolol (MJJ-1999) in adrenal medulla. Proc Soc Exp Biol Med 145 (1974) 1368-1371
94. Kelliher G., Widmer C., and Roberts J. Influence of the adrenal medulla on cardiac rhythm disturbances following actue coronary artery occlusion. In: Rogy P.-.E., and Rona G. (Eds). Recent advances in studies on cardiac structure and metabolism: vol. 10. The metabolism of contraction (1975), Univ. Park Press, Baltimore 387-400
95. Schott G.D., McLeod A.A., and Jewitt D.E. Cardiac arrhythmias that masquerade as epilepsy. Br Med J 1 (1977) 1454-1457
96. Schraeder P.L., Pontzer R., and Engel T.R. A case of being scared to death. Arch Intern Med 143 (1983) 1793-1794
97. Schwartz R.D., and Lathers C.M. GABA Neurotransmision, epileptogenic activity, and cardiac arrhythmias. In: Lathers C.M., and Schraeder P.L. (Eds). Epilepsy and sudden death (1990), Dekker, New York 293-308
98. Killam K.F., and Bain J.A. Convulsant hydrazides: I. In vitro and in vivo inhibition by convulsant hydrazides of enzymes catalyzed by vitamin B6. J Pharmacol Exp Ther 119 (1957) 255-262
99. Schwartz R.D. The GABAa receptor-gated ion channel: biochemical and pharmacological studies of structure and function. Biochem Pharmacol 37 (1988) 3369-3375
100. Rastogi S.K., and Ticku M.K. Anticonvulsant profile of drugs which facilitate GABAergic transmission on convulsions mediated by a GABAergic mechanism. Neuropharmacology 25 (1986) 175-185
101. Lathers C.M. Role of neuropeptides in the production of epileptogenic activity and arrhythmias. In: Lathers C.M., and Schraeder P.L. (Eds). Epilepsy and sudden death (1990), Marcel Dekker, New York 309-328
102. Lathers C.M., and Schraeder P.L. Arrhythmias associated with epileptogenic activity elicited by penicillin. In: Lathers C.M., and Schraeder P.L. (Eds). Epilepsy and sudden death (1990), Marcel Dekker, New York 157-167
103. Lathers CM, Schraeder PL. Experience-based teaching of therapeutics and clinical pharmacology of antiepileptic drugs. Sudden unexplained death in epilepsy: do antiepileptic drugs have a role? J Clin Pharmacol 1995;35:573-86; Quiz 586-7.
104. Schraeder PL, Lathers CM. Clinical pharmacology of antiepileptic drug use: clinical pearls about the perils of Patty. J Clin Pharmacol 1996;35:1120-35.
105. National Institutes of Health, National Institute of Neurological Disorders and Stroke. Workshop on sudden unexpected death in epilepsy, Rockville, MD, 12-14 November 2008.
106. Bigger T. Foreword. In: Lathers C.M., and Schraeder P.L. (Eds). Epilepsy and sudden death (1990), Marcel Dekker, New York iv-vii
107. Earnest M.P., Thomas G.E., Eden R.A., and Hossack K.F. The sudden unexplained death syndrome in epilepsy: demographic, clinical, and postmortem features. Epilepsia 33 (1992) 31031-31036
108. Ficker D.M., So E., Sehn W.K., et al. Population-based study of the incidence of sudden unexplained death in epilepsy. Neurology 51 (1998) 1270-1274
109. Walczak T.S., Leppik I.E., D'Amelio M., et al. Incidence and risk factors in sudden unexpected death in epilepsy: a prospective cohort study. Neurology 27 (2001) 519-525
110. Moran N.F., Poole K., Bell G., et al. Epilepsy in the United Kingdom: seizure frequency and severity, antiepileptic drug utilization and impact on life in 1652 people with epilepsy. Seizure 3 (2004) 425-433
111. Rugg-Gunn F.J., Simister R.J., Squirrell M., Holdright D.R., and Ducan J.S. Cardiac arrhythmias in focal epilepsy: a prospective long-term study. Lancet 364 (2004) 2212-2219
112. So E.L., Sam M.C., and Lagerlund T.L. Postictal central apnea as a cause of SUDEP: evidence from near-SUDEP incident. Epilepsia 41 (2000) 1494-1497
113. Bateman L.M., Li C.S., and Seyal M. Ictal hypoxemia in localization-related epilepsy: analysis of incidence, severity and risk factors. Brain 131 (2008) 3239-3245
114. Ieda M., Kimura K., Kanazawa H., and Fukuda K. Regulation of cardiac nerves: a new paradigm in the management of sudden cardiac death?. Curr Med Chem 15 (2008) 1731-1736
115. Ieda M., Kanazawa H., Ieda Y., et al. Nerve growth factor is critical for cardiac sensory innervations and rescues neuropathy in diabetic hearts. Circulation 114 (2006) 2351-2363
116. Ieda M., Kanazawa H., Kimura K., et al. Sema3a maintains normal heart rhythm through sympathetic innervation patterning. Nat Med 13 (2007) 604-612
117. 123I] metaiodobenzylguanidine-SPECT. Brain 124 (2001) 372-382
118. Kerling F, Dutsch M, Linke R, Kuwert T, Stefan H, Hilz MJ. Relation between ictal asystole and cardiac sympathetic dysfunctions shown by MIBG-SPECT. Acta Neurol Scand 2008 [Epub ahead of print].
119. Lathers C.M. Animal models to study nervous system sites of action for disease and pharmacological intervention. In: Lathers C.M., Schraeder P.L., Bungo M.W., and Leestma (Eds). Sudden death in epilepsy: forensic and clinical issues (2010), Francis & Taylor, New York 1-34
120. Schwartz R.D., Yu X., Katzman M.R., Hayden-Hixson D.M., and Perry J.M. Diazepam, given postischemia, protects selectively vulnerable neurons in the rat hippocampus and striatum. J Neurosci 15 1, Pt. 2 (1995) 529-539
121. So E.L. What is known about the mechanisms underlying SUDEP?. Epilepsia 49 Suppl. 9 (2008) 93-98
122. Tupal S., and Faingold C.L. Evidence supporting a role of serotonin in modulation of sudden death induced by seizures in DBA/2 mice. Epilepsia 47 (2006) 21-26
123. Lathers C.M., and Schraeder P.L. Clinical pharmacology: drugs as a benefit and/or risk in sudden unexpected death in epilepsy?. J Clin Pharmacol 42 (2002) 123-136
124. Lathers C.M., Schraeder P.L., and Claycamp H.G. Clinical pharmacology of topiramate vs lamotrigine vs phenobarbital: comparision of efficacy and side effects using odds ratios. J Clin Pharmacol 43 (2003) 491-503
125. Celiker A., Erdogan I., Karagoz T., and Ozer S. Clinical experiences of patients with catecholaminergic polymorphic ventricular tachycardia. Cardiol Young 19 (2009) 45-52
126. Houle M.S., Altschuld R.A., and Billman G.E. Enhanced in vivo and in vitro contractile responses to beta(2)-adrenergic receptor stimulation in dogs susceptible to lethal arrhythmias. J Appl Physiol 91 (2001) 1627-1637
127. Billman G.E., Kukielka M., Kelley R., Moustafa-Bayoumi M., and Altschuld R.A. Endurance exercise training attenuates cardiac beta2-adrenoceptor responsiveness and prevents ventricular fibrillation in animals susceptible to sudden death. Am J Physiol Heart Circ Physiol 290 (2006) H2590-H2599
128. Billman G.E., Castillo L.C., Hensley J., Hohl C.M., and Altschuld R.A. Beta2-adrenergic receptor antagonists protect against ventricular fibrillation: in vivo and in vitro evidence for enhanced sensitivity to beta2-adrenergic stimulation in animals susceptible to sudden death. Circulation 96 (1997) 1914-1922
129. Du X.J., Gao X.M., Jennings G.L., Dart A.M., and Woodcock E.A. Preserved ventricular contractility in infarcted mouse heart overexpressing beta(2)-adrenergic receptors. Am J Physiol Heart Circ Physiol 279 (2000) H2456-H2463
130. Lathers C.M., and Schraeder P.L. Stress and sudden death. Epilepsy Behav 9 (2006) 236-242
131. Lathers C.M., Koehler S.A., Wecht C.H., and Schraeder P.L. Forensic antiepileptic drug levels in 2001 autopsy cases of sudden, unexpected deaths in persons with epilepsy in Allegheny County Pennsylvania (2003), FDA Science Forum, Washington, DC
132. Lathers CM, Koehler SA, Wecht CH, Schraeder PL. Forensic antiepileptic drug levels in 2001 autopsy cases of sudden, unexpected deaths in persons with epilepsy in Allegheny County Pennsylvania. Presented at the annual meeting of the American College Clinical Pharmacology, Orlando, FL; September 2003.
133. Hughes J.R. A review of sudden unexpected death in epilepsy: prediction of patients at risk. Epilepsy Behav 14 (2009) 280-287
134. Ryvlin P, Tomson T, Montavont A. Excess mortality and sudden unexpected death in epilepsy. Presse Med 2009 [Epub ahead of print].
135. So E.L., Brainbridge J., Buchhalter J.R., et al. American Epilepsy Society and the Epilepsy Foundation Joint Task Force on Sudden Unexplained Death in Epilepsy. Epilepsia 50 (2009) 917-922
136. Scorza F.A., Arida R.M., and Cavalheiro E.A. Preventive measures for sudden cardiac death in epilepsy beyond therapies. Epilepsy Behav 13 (2008) 263-264
137. Terra-Bustamante V.C., Scorza C.A., de Albuquerque M., et al. Does the lunar phase have an effect on sudden unexpected death in epilepsy?. Epilepsy Behav 14 (2009) 404-406
138. Calderazzo L., Arida R.M., Cysneiros R.M., Cavalheiro E.A., and Scorza F.A. From sardines to salmon: influence of climate fluctuations on sudden unexpected death in epilepsy. Epilepsy Behav 14 (2009) 567-568
139. Scorza F.A., Cysneiros R.M., Arida R.M., et al. Adult hippocampal neurogenesis and sudden unexpected death in epilepsy: reality or just an attractive history?. Med Hypotheses 71 (2008) 914-922
140. Lathers CM. President and Dean, Albany College of Pharmacy, Union University. Profiles in Leadership Program. Presented at The Egg, Albany, NY; September 1995.
141. Lathers CM. Leadership needs nurturing environment. Presented at the Times Union Center, 22 October 1995.
142. Lathers CM. President's message. Presented at the American College Clinical Pharmacology (ACCP) annual meeting; 1994. ACCP Newsletter, December 1994.